Irving Bryan 4
4 · FIVE PRIME THERAPEUTICS INC · Filed Feb 27, 2019
Insider Transaction Report
Form 4
Irving Bryan
SVP, Research
Transactions
- Award
Common Stock
2019-02-25+10,000→ 32,271 total - Tax Payment
Common Stock
2019-02-26$11.95/sh−1,118$13,360→ 31,153 total - Award
Employee Stock Option (right to buy)
2019-02-25+58,000→ 58,000 totalExercise: $11.97Exp: 2029-02-24→ Common Stock (58,000 underlying)
Footnotes (2)
- [F1]Represents shares of restricted stock, which will vest according to the following schedule: one-third (1/3) of the restricted stock will vest on each of February 25, 2020, 2021 and 2022, provided the reporting person provides services to Five Prime Therapeutics, Inc. (the "Company") through each such date.
- [F2]The shares underlying the option vest at a rate of one forty-eighth (1/48) per month following February 25, 2019, provided the reporting person provides services to the Company through each such date.